Stay updated with breaking news from Pharmaceutical Turnkey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oncotelic has received a contract from BARDA to develop OT-101 to treat the long-term effects of respiratory distress after Covid-19 infection.
Japan’s MHLW has granted four new approvals for Merck’s humanised monoclonal antibody, Keytruda, to treat various types of cancers.
The Niemann-Pick Type C disease market is expected to grow from $128.35m last year to $188.35m in 2031 across the 3MM.
Covid-19 can temporarily diminish male fertility, an NIH-funded study found. The study, published in the American Journal of Epidemiology.